HIV patients may do just as well on fewer drugs, new study suggests

This study looked at HIV-positive adults who switched from a standard three-drug therapy to either a two-drug or a three-drug regimen. Researchers wanted to see if the two-drug option could reduce long-term side effects while keeping the virus under control. The main focus was on changes in immune system markers like CD8 cells and the CD4/CD8 ratio. Results help doctors choose safer long-term treatments for people living with HIV.